Allele Dmel\sli2
| General Information | |||
|---|---|---|---|
| Symbol | Dmel\sli2 | Species | D. melanogaster |
| Name | FlyBase ID | FBal0015700 | |
| Feature type | allele | Associated gene | Dmel\sli |
| Also Known As | slit2, sliIG107, slitIG107 | ||
Map (
GBrowse
)
![]() |
| ||
| Allele class | loss of function allele, amorphic allele - genetic evidence | ||
| Mutagen | ethyl methanesulfonate | ||
Recent Updates
|
|||
| Description |
What does this section display?
This section contains items that were added to this record for each release.
It currently only tracks new links between this FlyBase report and other
FlyBase data classes (e.g. genes, references, stocks) or controlled
vocabulary terms (e.g. GO, anatomy terms).
What does this section not display?
This section does not currently display links that were removed or gene model changes.
|
||
| Update Feed |
Click the icon below to subscribe to this FlyBase record and receive updates automatically through your
feed reader.
|
||
| FB2013_03 | |||
| FB2013_02 | |||
| All updates | Click here to see a list of all updates to this record from FB2010_08 and on. | ||
Nature of the Allele
| |||
| Allele class | |||
| Mutagen | |||
| Mutations Mapped to the Genome | |||
Type Location Additional Notes References point mutation evidence=experimental na_change=A11763000T pr_change=K1024|sli-PA,K1048|sli-PC,K1024|sli-PB,K102 4|sli-PD,K1048@|sli-PE reported_na_change=A3150T reported_pr_change=K?@ | |||
| Associated Sequence Data | |||
| DDBJ
/
EMBL / GenBank | DNA sequence Protein sequence Name | ||
| UniProtKB/Swiss-Prot | |||
| UniProtKB/TrEMBL | |||
| Progenitor genotype | |||
| Nature of the lesion | Statement Reference Amino acid replacement: K?@. Nucleotide substitution: A3150T. | ||
| Cytology | |||
Phenotypic Data
| |||
Phenotypic Class
| |||
Phenotype Manifest In
| |||
axon & pCC neuron chordotonal organ & axon | lateral chordotonal organ & embryo & nerve terminal eye photoreceptor cell & axon (with slik04807b) mesothoracic dorsal triscolopidial chordotonal organ dch3 & scolopidial dendrite metathoracic dorsal triscolopidial chordotonal organ dch3 & scolopidial dendrite | |||
Detailed Description
| |||
Statement Reference Tracheal dorsal branch fusion occurs normally in the tracheal system of sli[2]/+ third instar larvae Mild ectopic ap neuron crossing defects are seen in heterozygous sli[2] stage 16 embryos. In sli[2] mutant embryos the ventral longitudinal muscles cross dorsally over the CNS, meeting those from the other side to form ectopic muscle attachments along the ventral midline. Many of the dorsal abdominal clusters in sli[2] mutant animals have branches that exceed the normal level of extension at approximately 21 and 22 hours after egg laying. The maximal dendrite length with respect to the most dorsally positioned neuronal cell body is significantly altered in mutants.
Class IV sli[2] mutant neurons display dendrite over-elongation and reduced branching. Class IV neurons show less high order branches and form longer dendrite process compared to control embryos. The number of branches of class IV neurons is significantly decreased in robo[1] mutants at 22 hours after egg laying. The dorsal elongation and the average branch length are significantly increased. In robo2 embryos, the pCC axons aberrantly cross the midline. sli[2] mutant embryos present a very severe fused commissure phenotype. sli2 embryos show defective heart development. These embryos have breaks in the continuity of the adherent cardial cells during migration, which can lead to lesions in the final heart vessel. Sometimes, a few cardial cells are not incorporated into the heart, nuclei sometimes cross the midline and irregular bulges in cardial alignment are produced. The hearts of sli2 embryos have either no lumen, or a very small one, and an expanded basolateral zone. Dorsal closure is not affected in these mutants.
sli2/+ mutants have a normal heart. Although the appropriate number of cardioblasts are specified in sli2 embryos, cell adhesion between cardioblasts is lost. Thus, in 97% of sli2 embryos, the cardioblasts fail to form two continuous rows of cells, showing frequent gaps and inappropriate cell clustering and intermingling with the flanking pericardial cells: approximately 104 Mef2-positive cardioblast nuclei form two rows at the dorsal midline in wild type embryos, whereas there are only approximately 87.9 Mef2-positive cells at this position in sli2 mutant embryos. The rows of pericardial cells that flank the rows of cardioblasts are also misaligned in sli2 embryos, and often show gaps that frequently correspond with the gaps in the rows of cardioblasts.
The shape of cardioblasts in sli2 embryos is abnormal. 90% of sli2 embryos have salivary glands that curve medially towards the CNS midline, instead of lying parallel to the midline in the wild-type position. When the bilateral rows of myocardial progenitors have reached the dorsal midline, they fail to align properly in sli2 mutants compared to wild-type. There are two types of myocardial cell misalignments: type I consist of irregularities in the myocardial cell rows and type II, in addition, has gaps and triple lines of myocardial cells. The apical-lateral polarity of the heart tube is disrupted in sli2 mutants. Normal separation of primordial germ cells into lateral clusters on each side of the embryo is observed in homozygous and heterozygous sli2. 33% of thoracic segments show transformation of the dch3 chordotonal organs to a morphology resembling that of abdominal lch5 chordotonal organs in mutant embryos; the transformed "dch3" organs are positioned laterally and have dendrites pointing dorsally. The vp1-4a external sensory organs in the abdomen are correctly specified and positioned in stage 16 mutant embryos. However, the ventral multidendritic (vmd) neuron cluster contains a variable number of md neurons, ranging from 4 (one md neuron missing in 29% of hemisegments) to 6 (one extra md neuron in 24% of hemisegments). The variation in number of neurons in the vmd cluster is due to variation in the number of vmd1a neurons in the cluster (the wild-type vmd cluster contains 1 vmd1a neuron). By comparing the vmd cluster on each side of the midline in a segment, it is seen that whenever two vmd1a neurons are seen in one hemisegment, no vmd1a neuron is seen in the contralateral hemisegment, strongly suggesting that the vmd1a neuron can cross the midline in these embryos. In 3 segments, the loss of the vmd1a neuron did not correlate with its duplication in the contralateral hemisegment. In these cases, the missing vmd1a neuron has probably remained at the midline. Analysis of the position of the vmd1a neuron and its precursor cells in sli2 mutant embryos at different stages indicates directly that the vmd1a neuron can cross the midline in these embryos. slik04807b/sli2 third instar larvae show defects in photoreceptor axon targeting, with gaps in the lamina and increased numbers of axons entering the medulla. slik04807b/sli2 animals show disruption of the lamina glia layer; clumps of glia and gaps in the glial layers are seen. The regions of photoreceptor axon mistargeting correlate with areas of lamin glial disruption. Many distal cell neurons enter the base of the lamina in slik04807b/sli2 third instar larvae and some distal cell neurons invade the lamina neuropil, disrupting photoreceptor innervation. Heterozygous mutants do not exhibit significant longitudinal axon ectopic midline crossing defects. lch5 axons stall before turning point TP1 in 10% of hemisegments or misproject to the v'ch1 pathway in 12% of hemisegments of mutant embryos. Dorsal cluster axons stall in the lateral region of the embryo in 10% of hemisegments or project in abnormal directions (usually after reaching the lateral region) in 8% of hemisegments. Mutant embryos have defects in the tracheal system, including the spiracular branch and transverse connective. Motor axon projections are often disrupted in mutant embryos. In mutant hemisegments which have a normal location of the spiracular branch, normal position and orientation of the dorsal and lateral sensory neuron cell bodies and normal motor axon trajectories, 14% of the hemisegments have lch5 axons projecting to the v' pathway and 28% of hemisegments have lesA/ldaA axons projecting to the v' pathway, while the dorsal cluster axons follow a normal trajectory to the lateral region in all the hemisegments. Homozygous embryos show three Fas2 fascicles collapsed on the midline. The ch neurons project across the midline and either stall or reach as far as the outer far edge of the CNS. Either way they fail to branch. Heterozygous embryos only extremely rarely show Fas2-expressing axons crossing the midline. One or two Fas2-positive axon bundles cross the midline in about 36% of heterozygous embryos. Heterozygotes show 4% ectopic crossing of the midline by axons in the embryonic central nervous system. 1.0% of expected mutant embryos hatch as first instar larvae. The latest observed stage of mutants is L1. Nerve cord length is 88% of embryo length. Midline guidance failure of repellence phenotype, evidenced by midline crossing, is severe. Mutant embryos show complete fusion of the longitudinal and commissural nerve trunks - few intersegmental connections are maintained. 6.8 ventral oblique muscles per segment remain on the dorsal surface of the ventral nerve cord, instead of having migrated to the edges and inserted into the ectoderm. All CNS axons converge on the midline which is displaced ventrally. The ventral muscles fail to migrate away from the midline in mutant embryos, resulting in muscles that extend over the dorsal surface of the CNS. The initial migration defect seen in the ventral muscle precursors of sli2 embryos is rescued by expression of sliScer\UAS.cKa under the control of Scer\GAL4sim.P3.7. However, striking defects are seen during the second phase, as muscles extend towards their (muscle attachment sites) MASs. Many muscles that normally attach at sli-positive MASs are instead attached to the wrong places in the epidermis. Muscles 6 and 7 either do not reach their MASs or make abnormal connections with the epidermis. Muscle 5 is often missing or is not properly attached at one or both ends. Muscle 4 is also often not properly attached. sli2 embryos in which the midline has been rescued by expressing sliScer\UAS.cKa under the control of Scer\GAL4sim.P3.7 often show misinsertion of dorsal muscles 1,2, 9 and 10. However, the overall position of these muscles is not dramatically affected in these embryos. Muscles 21 to 23 are largely unaffected although occasionally an extra muscle is seen. 1% of segments show crossing of the midline by muscles 6/7, 54% show abnormal insertion of muscle 5 and 36% show abnormal insertion of muscles 6/7 (either failing to reach their specific muscle insertion sites in the epidermis - 12%, or reaching the epidermis but making abnormal connections - 24%). In sli2 embryos expressing sliScer\UAS.cKa under the control of Scer\GAL4en-e16E, 49% of segments show muscle cells aligned with sites of ectopic sli expression. In sli2 embryos expressing sliScer\UAS.cKa under the control of Scer\GAL4ptc-559.1, 20% of segments show muscle cells aligned with sites of ectopic sli expression. Ventral longitudinal muscles 6 and 7 cross the midline in 90% of segments in mutant embryos. Muscle 13 also occasionally crosses the midline. Muscle 5 is present, although it is frequently attached to the wrong site in the epidermis. The GMC-1 in mutants frequently (about 10%) divide symmetrically to generate two RP2s instead of an RP2 and a sib. Approximately 24% of heterozygous embryos show periodic crossovers of Fas2-positive axons across the midline. All axons in the longitudinal connectives are collapsed towards a single midline tract. MP pioneers are medially displaced in stage 12/0 mutant embryos. Contralaterally projecting axons persist in sli mutants despite fusion of longitudinal tracts. Midline glia are displaced to the ventral limit of the neuropil, and maintain contact with commissural axons. Anterior and posterior to the commissural axons the neuropil of sli mutant nerve cords contains many more growth cone filopodia, and fewer axons than wild type. The longitudinal connectives appear to recross the midline as they project anteriorly or posteriorly, similarly to robo mutants. Most mesectodermal cells line the ventral midline. The ventral oblique muscles do not insert below the cord, but cross the dorsal surface of the cord and insert contralaterally with the ventral longitudinal muscles. When the mutant phenotype is partially rescued by the sliScer\UAS.cBa, Scer\GAL4sim.P3.7 combination, midline structures are partially restored, but errant axons continue to cross the midline. This phenoytpe is comparable to that of sli532 or a robo hypomorph. Mesectodermal cytoarchitecture is not restored. Embryos heterozygous for either robo1 or sli2 show deviation of longitudinal fascicles towards the midline in less than 5% of segments. Axons enter the midline, but fail to leave it and instead run along it in one longitudinal tract in the central nervous system (CNS) of sli2 embryos. The pCC axon aberrantly enters the midline in homozygous embryos, where it fasciculates with its contralateral homologue. The pCC homologues then extend anteriorly along the midline. In some segments the aCC axon crosses the midline and fasciculates with the axon of its contralateral homologue (in contrast to wild-type where it normally extends ipsilaterally away from the midline). Commissural axons such as SP1 do not leave the midline. The ventral muscles extend over the dorsal surface of the CNS. In stage 13 embryos the dorsal median cells are mislocalised to lateral positions away from the midline. By stage 16 the cells are absent from most segments. Mutant phenotype as assayed by Ecol\lacZrp staining: midline missing. Mutant phenotype of lateral chordotonal axons includes: shorter axons, defasciculated axons or dorsally routed axons. In stage 12/3 homozygous embryos the commissures are pioneered but are closer together than wild type. By stage 14 the longitudinal tracts have collapsed at the midline. Midline glia reach the dorsal midline by stage 12/5, become ventrally displaced during stage 13 and by stage 14 are spread from the dorsal to ventral surface. VUM neurons are present at the proper position during stage 11 by are misplaced ventrally by stage 13. These neurons are still present at the ventral midline at stage 14. In stage 13 embryos the wild-type number of MP1 neurons are present but displaced ventrally, by stage 14 they are fused at the midline. en+ neurons are present at stage 14 but are displaced. Longitudinal tracts fuse at the ventral midline, though the glial scaffold is normal. Absence of commissures and the collapse of the longitudinal tracts into a single fused tract at the midline. The midline precursor cells are displaced ventrally and do not differentiate properly. The posterior commissure sometimes forms and the anterior commissure is always initially formed, but the commissures are narrower and are not as straight or regular in shape. The commissures disappear as the midline precursors displace. The presence of Ecol\lacZsim.7.8 construct shows that the midline cells are disorganised compared to wild type at stage 11 and at stage 13 are clustered near the ventral surface of the embryo leading to the collapse of the two lateral CNS hemiganglia and fusion of the longitudinal connectives. | |||
External Data
| |||
| Linkouts | |||
Interactions
| |||
|
|||
Phenotypic Class
| |||
Enhanced by | |||
Statement Reference shot3/shot[+], sli2 has neuroanatomy defective | embryonic stage phenotype, enhanceable by exba[+]/exba2 sli2 has neuroanatomy defective | dominant | embryonic stage 16 phenotype, enhanceable by kuz[+]/kuz112 sli2 has neuroanatomy defective | dominant | embryonic stage 16 phenotype, enhanceable by kuz[+]/kuz2583 sli2 has neuroanatomy defective | dominant | embryonic stage 16 phenotype, enhanceable by kuz[+]/kuzH143 sli2 has neuroanatomy defective | dominant | embryonic stage 16 phenotype, enhanceable by Scer\GAL4ap-md544/kuzDN.Scer\UAS | |||
NOT Enhanced by | |||
Statement Reference robo1, sli2 has neuroanatomy defective | embryonic stage 16 phenotype, non-enhanceable by Df(3R)ED4688 robo1, sli2 has neuroanatomy defective | embryonic stage 16 phenotype, non-enhanceable by Nedd4EY00500/Scer\GAL41407 robo1, sli2 has neuroanatomy defective | embryonic stage 16 phenotype, non-enhanceable by Nedd4EY00500/Scer\GAL4elav.PLu robo1, sli2 has neuroanatomy defective | embryonic stage 16 phenotype, non-enhanceable by Nedd4Scer\UAS.T:Hsap\MYC/Scer\GAL41407 robo1, sli2 has neuroanatomy defective | embryonic stage 16 phenotype, non-enhanceable by Nedd4Scer\UAS.T:Hsap\MYC/Scer\GAL4elav.PLu | |||
Suppressed by | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4elav.PLu, sli2 has neuroanatomy defective phenotype, suppressible | partially by PakScer\UAS.T:Myr-Src64B, Scer\GAL4elav.PLu robo1, sli2 has neuroanatomy defective | embryonic stage 16 phenotype, suppressible by enaScer\UAS.cCa/Scer\GAL4elav.PLu β-Specem6, robo[+]/robo1, sli2 has neuroanatomy defective phenotype, suppressible | partially by β-SpecScer\UAS.T:Hsap\MYC/Scer\GAL4elav.PLu | |||
NOT suppressed by | |||
Statement Reference β-Specem6, sli2 has neuroanatomy defective | dominant phenotype, non-suppressible by Scer\GAL4ap-md544/β-SpecScer\UAS.T:Hsap\MYC | |||
Enhancer of | |||
Statement Reference sli2/sli[+] is an enhancer of neuroanatomy defective | dominant | embryonic stage 16 phenotype of kuzH143 sli2/sli[+] is an enhancer of neuroanatomy defective | embryonic stage 16 phenotype of Scer\GAL4ap-md544, kuzDN.Scer\UAS sli2/sli[+] is an enhancer of neuroanatomy defective phenotype of Ggal\MLCKct.Scer\UAS, Scer\GAL4ftz.ng | |||
NOT Enhancer of | |||
Statement Reference | |||
Suppressor of | |||
Statement Reference sli2/sli[+] is a suppressor | partially of neuroanatomy defective phenotype of Scer\GAL4elav-C155, leaEP2582 | |||
NOT Suppressor of | |||
Statement Reference sli2 is a non-suppressor of neuroanatomy defective | embryonic stage phenotype of Scer\GAL4elav.PLu, fraΔC.Scer\UAS.T:Ivir\HA1, fraunspecified | |||
Other | |||
Statement Reference | |||
Phenotype Manifest In
| |||
Enhanced by | |||
Statement Reference robo[+]/robo1, sli2 has medial longitudinal fascicle | ectopic phenotype, enhanceable by β-SpecG0074 robo[+]/robo1, sli2 has medial longitudinal fascicle | ectopic phenotype, enhanceable by β-SpecG0198 sli2 has longitudinal connective | embryonic stage 16 phenotype, enhanceable by Scer\GAL4ap-md544/kuzDN.Scer\UAS sli2 has midline crossing tract | embryonic stage 16 phenotype, enhanceable by Scer\GAL4ap-md544/kuzDN.Scer\UAS sli2 has presumptive embryonic/larval central nervous system phenotype, enhanceable by capt[+]/captB99 sli2 has presumptive embryonic/larval central nervous system phenotype, enhanceable by capt10/capt[+] sli2 has presumptive embryonic/larval central nervous system phenotype, enhanceable by captk01217/capt[+] sli2 has presumptive embryonic/larval central nervous system phenotype, enhanceable by Sdc[+]/Sdcunspecified | |||
NOT Enhanced by | |||
Statement Reference robo1, sli2 has longitudinal connective | embryonic stage 16 phenotype, non-enhanceable by Df(3R)ED4688 robo1, sli2 has longitudinal connective | embryonic stage 16 phenotype, non-enhanceable by Nedd4EY00500/Scer\GAL41407 robo1, sli2 has longitudinal connective | embryonic stage 16 phenotype, non-enhanceable by Nedd4EY00500/Scer\GAL4elav.PLu robo1, sli2 has longitudinal connective | embryonic stage 16 phenotype, non-enhanceable by Nedd4Scer\UAS.T:Hsap\MYC/Scer\GAL41407 robo1, sli2 has longitudinal connective | embryonic stage 16 phenotype, non-enhanceable by Nedd4Scer\UAS.T:Hsap\MYC/Scer\GAL4elav.PLu robo1, sli2 has midline crossing tract | embryonic stage 16 phenotype, non-enhanceable by Df(3R)ED4688 robo1, sli2 has midline crossing tract | embryonic stage 16 phenotype, non-enhanceable by Nedd4EY00500/Scer\GAL41407 robo1, sli2 has midline crossing tract | embryonic stage 16 phenotype, non-enhanceable by Nedd4EY00500/Scer\GAL4elav.PLu robo1, sli2 has midline crossing tract | embryonic stage 16 phenotype, non-enhanceable by Nedd4Scer\UAS.T:Hsap\MYC/Scer\GAL41407 robo1, sli2 has midline crossing tract | embryonic stage 16 phenotype, non-enhanceable by Nedd4Scer\UAS.T:Hsap\MYC/Scer\GAL4elav.PLu | |||
Suppressed by | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4elav.PLu, sli2 has longitudinal connective phenotype, suppressible | partially by PakScer\UAS.T:Myr-Src64B, Scer\GAL4elav.PLu robo1, sli2 has longitudinal connective | embryonic stage 16 phenotype, suppressible by enaScer\UAS.cCa/Scer\GAL4elav.PLu robo1, sli2 has midline crossing tract | embryonic stage 16 phenotype, suppressible by enaScer\UAS.cCa/Scer\GAL4elav.PLu sli2 has muscle attachment site | ectopic phenotype, suppressible by Scer\GAL4Mef2.PR/EgfrDN.Scer\UAS sli2 has muscle attachment site | ectopic phenotype, suppressible by sdΔ88-159.Scer\UAS/Scer\GAL4Mef2.PR β-Specem6, robo[+]/robo1, sli2 has medial longitudinal fascicle | ectopic phenotype, suppressible | partially by β-SpecScer\UAS.T:Hsap\MYC/Scer\GAL4elav.PLu | |||
NOT suppressed by | |||
Statement Reference β-Specem6, sli2 has embryonic/larval neuron phenotype, non-suppressible by Scer\GAL4ap-md544/β-SpecScer\UAS.T:Hsap\MYC | |||
Enhancer of | |||
Statement Reference sli2, robo[+], robo1 is an enhancer of medial longitudinal fascicle | ectopic phenotype of β-Specem6 sli2, robo[+], robo1 is an enhancer of medial longitudinal fascicle | ectopic phenotype of β-SpecG0074 sli2, robo[+], robo1 is an enhancer of medial longitudinal fascicle | ectopic phenotype of β-SpecG0198 sli2, Scer\GAL4ap-md544, sli[+] is an enhancer of longitudinal connective | embryonic stage 16 phenotype of Scer\GAL4ap-md544, kuzDN.Scer\UAS sli2, Scer\GAL4ap-md544, sli[+] is an enhancer of midline crossing tract | embryonic stage 16 phenotype of Scer\GAL4ap-md544, kuzDN.Scer\UAS sli2/sli[+] is an enhancer of longitudinal connective phenotype of Ggal\MLCKct.Scer\UAS, Scer\GAL4ftz.ng sli2/sli[+] is an enhancer of presumptive embryonic/larval central nervous system phenotype of Ptp10D1, Ptp69D1/Ptp69D8ex25 sli2/sli[+] is an enhancer of presumptive embryonic/larval central nervous system phenotype of Sdcunspecified sli2/sli[+] is an enhancer of ventral nerve cord commissure phenotype of Ptp10D1, Ptp69D1/Ptp69D8ex25 | |||
NOT Enhancer of | |||
Statement Reference | |||
Suppressor of | |||
Statement Reference sli2/sli[+] is a suppressor | partially of abdominal lateral pentascolopidial chordotonal organ lch5 phenotype of Scer\GAL4elav-C155, leaEP2582 sli2/sli[+] is a suppressor | partially of dorsal branch | third instar larval stage phenotype of Sdc2639 sli2/sli[+] is a suppressor of dorsal branch | third instar larval stage phenotype of Scer\GAL4btl.PS, SdcdsRNA.Scer\UAS.cSa sli2 is a suppressor | partially of ventral nerve cord commissure phenotype of Scer\GAL4elav.PLu, leaScer\UAS.cSa sli2 is a suppressor of A1-7 lateral transverse muscle 1 phenotype of Scer\GAL4how-24B/Scer\GAL4how-24B, roboScer\UAS.cKa sli2 is a suppressor of A1-7 lateral transverse muscle 2 phenotype of Scer\GAL4how-24B/Scer\GAL4how-24B, roboScer\UAS.cKa sli2 is a suppressor of A1-7 lateral transverse muscle 3 phenotype of Scer\GAL4how-24B/Scer\GAL4how-24B, roboScer\UAS.cKa | |||
NOT Suppressor of | |||
Statement Reference sli2 is a non-suppressor of ventral nerve cord commissure | embryonic stage phenotype of Scer\GAL4elav.PLu, fraΔC.Scer\UAS.T:Ivir\HA1, fraunspecified | |||
Other | |||
Statement Reference | |||
Additional Comments
| |||
Genetic Interactions
| |||
Statement Reference sli[2]/+ suppresses the dorsal branch fusion phenotype seen when Sdc[dsRNA.Scer\UAS.cSa] is expressed under the control of Scer\GAL4[btl.PS].
One copy of sli[2] partially suppresses the dorsal branch fusion phenotype seen in the tracheal system of Sdc[2639] homozygous third instar larvae. One copy each of sli[2] and Sdc[2639] does not produce any dorsal branch fusion defects. kuz[H143], sli[2] transheterozygous stage 16 embryos display a stronger ectopic ap neuron crossing phenotype than either mutant alone.
kuz[2583]/+ enhances the ectopic ap neuron crossing phenotype seen in sli[2] heterozygous stage 16 embryos.
kuz[112]/+ enhances the ectopic ap neuron crossing phenotype seen in sli[2] heterozygous stage 16 embryos.
Expression of kuz[DN.Scer\UAS] in ipsilateral ap neurons under the control of Scer\GAL4[ap-md544] in a sli[2]/+ mutant background produces more severe ap axon midline crossing defects in stage 16 embryos than in either mutant alone. Blocking vg function through expression of sd[Δ88-159.Scer\UAS] in ventral longitudinal muscle cells (under the control of Scer\GAL4[Mef2.PR]) that abnormally migrate along the midline owing to a sli[2] mutant background, leads to fewer and smaller muscle-muscle adhesions.
Increasing vg function through expression of vg[2.Scer\UAS] in ventral longitudinal muscle cells (under the control of Scer\GAL4[Mef2.PR]) that abnormally migrate along the midline owing to a sli[2] mutant background, leads to more and larger muscle-muscle adhesion sites.
Increasing vg function through expression of vg[2.Scer\UAS] in somatic muscle cells (under the control of Scer\GAL4[Mef2.PR]) of sli[2] mutants greatly enhances the adhesion level between the midline-crossing ventral longitudinal muscles.
Expression of Egfr[DN.Scer\UAS] in somatic muscle cells (under the control of Scer\GAL4[Mef2.PR]) of sli[2] mutants decreases the size and/or number of adhesion sites along the midline. The longitudinal tract midline crossing phenotype seen in communspecified mutants is significantly enhanced by sli2/+, both in terms of the numbers of segments and the number of embryos affected. sli2, robo1/+ embryos show midline axon guidance defects, with on average two to three medial longitudinal fascicle ectopically crossing the midline per embryo.
β-Specem6/Y; sli2, robo1/+ show an enhancement of the midline axon guidance defects seen in β-Specem6/Y and sli2, robo1/+ embryos as more medial longitudinal fascicles ectopically cross the midline in the triple mutant. An enhancement is also seen in β-SpecG0074/Y; sli2, robo1/+ and β-SpecG0198/Y; sli2, robo1/+ triple mutant embryos. Expression of β-SpecScer\UAS.T:Hsap\MYC, under the control of Scer\GAL4elav.PLu, rescues the phenotype of the triple mutants back to the milder phenotype seen in sli2, robo1/+ embryos.
The Apterous neuron axon guidance phenotype of sli2/+ embryos is enhanced in β-Specem6/Y; sli2/+ and β-SpecG0198/Y; sli2/+ embryos, although the timing at which the defects appear is not altered. Expression of β-SpecScer\UAS.T:Hsap\MYC under the control of Scer\GAL4ap-md544 is unable to rescue the β-Specem6/Y; sli2/+ phenotype back to the sli2/+ severity. Expression of fra[ΔC.Scer\UAS.T:Ivir\HA] driven by Scer\GAL4[elav.PLu] in a fra[unspecified] sli[2] double mutant background results in a phenotype similar to the phenotype observed for overexpression of fra[ΔC.Scer\UAS.T:Ivir\HA] in a fra[unspecified] single mutant background, where many axons fail to cross the midline. The sli2 heart development phenotype is enhanced by the following alleles, as judged by the appearance of defective heart formation in doubly heterozygous embryos: mys1, scb01288, LanA9-32, wbSF11, vkg177, vkgP10038 and rhea1. The following alleles produce a mild heart phenotype when doubly heterozygous with lea2, leaS4-18, NrtM54 and Ras85D05703.
IlkZCL3111/+; sli2/+ embryos show defects in heart formation including delays in midline fusion of cardial cells, which suggests a delay in dorsal closure.
The following doubly heterozygous embryos show no defects in heart formation: mewM6/+; sli2/+ embryos, Tigx/+, sli2/+ embryos and dock04723/+, sli2/+ embryos.
Dorsal closure is delayed in sli2/+, scb01288/+ embryos but is complete at hatching. In robo[1],sli[2] /+,+ stage 16 embryos, FasII axons cross the midline in three to five segments per embryo.
Expression of Nedd4[Scer\UAS.T:Hsap\MYC] under the control of either Scer\GAL4[elav.PLu] or Scer\GAL4[1407] does not enhance the midline crossing phenotype seen in transheterozygous sli[2] robo[1] stage 16 embryos.
Expression of Nedd4[EY00500] under the control of either Scer\GAL4[elav.PLu] or Scer\GAL4[1407] does not enhance the midline crossing phenotype seen in transheterozygous sli[2] robo[1] stage 16 embryos.
Df(3R)ED4688 does not enhance the midline crossing phenotype seen in transheterozygous sli[2] robo[1] stage 16 embryos.
Expression of ena[Scer\UAS.cCa] under the control of Scer\GAL4[elav.PLu] suppresses the midline crossing phenotype seen in transheterozygous sli[2] robo[1] stage 16 embryos. The transformation of abdominal lch5 chordotonal organs to a morphology resembling thoracic dch3 chordotonal organs that is seen in larvae expressing leaEP2582 under the control of Scer\GAL4elav-C155 is attenuated if the larvae also carry one copy of sli2; only 17.2% of abdominal segments have partial or complete transformation of the lch5 organs in the double mutant larvae at 25oC. sli2 Sdcunspecified double heterozygous embryos have additional longitudinal transverse muscles. The number of Fas2-expressing inner fascicles that cross the midline in the double heterozygotes (3.3%) is increased compared to sli2 single heterozygotes (0.6%). Sdcunspecified homozygous embryos that are also heterozygous for sli2 show an enhanced axonal guidance defect with multiple midline crossings of the fascicles. The combination of heterozygous sli2 and pan-neural overexpression of Rho1N19.Scer\UAS (expressed under the control of Scer\GAL4elav.PLu) leads to longitudinal axon ectopic midline crossing defects. An average of 2 defects are seen per animal, and an average of 18% of segments have defects. If expression of Rho1N19.Scer\UAS is driven by Scer\GAL4ftz.ng, 7.4 defects are seen per animal, and an average of 67% of segments have defects. The combination of heterozygous sli2 and pan-neural overexpression of Rac1N17.Scer\UAS (expressed under the control of Scer\GAL4elav.PLu) leads to longitudinal axon ectopic midline crossing defects. An average of 8.3 defects are seen per animal, and an average of 75% of segments have defects. If expression of Rac1N17.Scer\UAS is driven by Scer\GAL4ftz.ng 4 defects are seen per animal, and an average of 36% of segments have defects. The combination of heterozygous sli2 and pan-neural overexpression of Cdc42N17.Scer\UAS (expressed under the control of Scer\GAL4elav.PLu) does not cause longitudinal axon ectopic midline crossing defects. The combination of heterozygous sli2 and pan-neural overexpression of PakScer\UAS.T:Myr1 under the control of Scer\GAL4elav.PLu leads to longitudinal axon ectopic midline crossing defects. An average of 5.6 defects are seen per animal, and an average of 51% of segments have defects. The combination of heterozygous sli2 and pan-neural overexpression of PakScer\UAS.T:Hsap\MYC under the control of Scer\GAL4elav.PLu leads to longitudinal axon ectopic midline crossing defects. An average of 1.2 defects are seen per animal, and an average of 11% of segments have defects. Co-expression of PakScer\UAS.T:Myr1 partially suppresses longitudinal axon ectopic midline crossing defects seen in sli2/+, Rac1N17.Scer\UAS ; Scer\GAL4elav.PLu animals. An average of 5 defects are seen per animal, and an average of 45% of segments have defects. The combination of heterozygous sli2 and Rac1J11 leads to an enhancement of the longitudinal axon ectopic midline crossing defects. An average of 4.8 defects are seen per animal, and an average of 44% of segments have defects. The combination of heterozygous sli2 and Rac2Δ leads to longitudinal axon ectopic midline crossing defects. An average of 1.4 defects are seen per animal, and an average of 13% of segments have defects. The combination of heterozygous sli2 and MtlΔ leads to longitudinal axon ectopic midline crossing defects. An average of 1.4 defects are seen per animal, and an average of 13% of segments have defects. 98% of lolaORE120 sli2/lolaORE120 embryos show Fas2-expressing axons crossing the midline. There are an average of 4.8 crossovers per affected embryo. sli2 robounspecified double mutants exhibit midline guidance errors in 44% of embryonic segments (as assayed with Fas2). Embryos with a single copy of sli2 and dock04723 have midline guidance errors in 77% of embryonic segments, sometimes involving all axon fascicles (as assayed with Fas2). In mys1/+ sli2/+ double heterozygous mutants the frequency of midline guidance errors is increased over the level observed in mys1 homozygous mutants. Apart from midline axon crossings in one-third of the segments, the longitudinal tracts (as visible with Fas2) appear normal. In mewM6/+ sli2/+ double heterozygous mutants the frequency of midline guidance errors is increased over the level observed in mewM6 homozygous mutants. Less than 10% of segments revealed midline guidance errors in mewM6/+ sli2/+ embryos. The frequency of ectopic crossing of the midline by axons in the central nervous system seen in sli2 heterozygous embryos is increased if they are also heterozygous for captB99, captk01217, capt10 or Abl2. When sli2/sli2 is in combination with unc-5Scer\UAS.T:Ivir\HA1,T:wg, Scer\GAL4elav.PLu the interaction is difficult to interpret - collapse of longitudinal fibers onto the midline is hindered, but midline cells are still displaced. The lateral transverse muscles make normal attachments in 98% of segments in embryos expressing roboScer\UAS.cKa under the control of Scer\GAL4how-24B that are also mutant for sli2. 6% of segments show crossing of the midline by muscles 6/7, 8% show abnormal insertion of muscle 5 and 11% show abnormal insertion of muscles 6/7 in sli2 robo1 double mutant embryos. 1% of segments show crossing of the midline by muscles 6/7, 5% show abnormal insertion of muscle 5 and 3% show abnormal insertion of muscles 6/7 in sli2 leaX123 double mutant embryos. 15% of segments show crossing of the midline by muscles 6/7, 31% show abnormal insertion of muscle 5 and 16% show abnormal insertion of muscles 6/7 in sli2 robo1 leaX123 triple mutant embryos. The addition of leaEP2582 (driven by Scer\GAL4elav.PLu) to homozygous sli2 embryos has no effect on the embryonic ventral nerve cord phenotype seen in these embryos. The Ptp10D1; Ptp69D1/Ptp69D8ex25 double mutant phenotype is significantly enhanced by one copy of sli2; more Fas2-positive axons cross the midline, the longitudinal tracts move closer together and more extensive commissural fusion is seen. 36% of segments contain Fas2-positive neurons inappropriately crossing the midline in sli2/robo1 double heterozygous embryos, in contrast to either single heterozygote which show defects in 1 or 0% of segments. 39% of segments contain Fas2-positive neurons inappropriately crossing the midline in sli2/robo4 double heterozygous embryos, in contrast to either single heterozygote which show defects in 1% of segments. Dominantly suppresses the wing blister phenotype of if3 flies. | |||
Xenogenetic Interactions
| |||
Statement Reference Fas2-positive axon bundles cross the midline in 100% of sli2/+ embryos which are also expressing Ggal\MLCKct.Scer\UAS under the control of Scer\GAL4ftz.ng. The penetrance of the Fas2-positive axon crossover phenotype is increased in sli2 embryos that also carry Khc::Ggal\MLCKKA.ftz compared to either single mutant alone. | |||
Complementation & Rescue Data
| |||
| Rescued by | |||
| Partially rescued by | |||
| Not rescued by | |||
| Comments | Expression of either sliScer\UAS.cBa or sliΔL1-L4.Scer\UAS under the control of Scer\GAL4B2-3-30 leads to a significant recovey in heart cell morphology. Expression of sliScer\UAS.cKa under the control of Scer\GAL4Mef2.PR (which drives expression in all cardioblasts and somatic muscle cells before they begin their migration toward the dorsal midline) significantly rescues the sli2 mutant phenotype in 95% of cases. The cardioblasts adhere to each other and there are no visible gaps between adjacent cardioblasts and pericardial cells. Rescued embryos show a similar number of of Mef2-positive cardioblasts at the dorsal midline and columnar-shaped cardioblasts similar to wild type controls. The midline is rescued in sli2 embryos expressing sliScer\UAS.cKa under the control of Scer\GAL4sim.P3.7. | ||
Stocks
( 2 ) | |||
| Bloomington | |||
| Kyoto | |||
Notes on Origin
| |||
| Discoverer | |||
Comments
| |||
Protein null. | |||
External Crossreferences & Linkouts
| |||
| Other Crossreferences | |||
| Linkouts | |||
Synonyms & Secondary IDs
( 7 ) | |||
| Reported As | |||
| Symbol Synonym | sli2 sliIG7 sliIG107 slit slit2 (Fan et al., 2003, Kraut and Zinn, 2004, Johnson et al., 2004, Steigemann et al., 2004, Parsons et al., 2003, Zlatic et al., 2003, Wills et al., 2002, Kim et al., 2002, Keleman and Dickson, 2001, Battye et al., 2001, Kramer et al., 2001, Kidd et al., 1999, Garbe et al., 2007, Simionato et al., 2007, Dimitrova et al., 2008, Coleman et al., 2010, Keleman et al., 2005, Schulz et al., 2011, Lee et al., 2011) slitIG107 unnamed | ||
| Name Synonym | |||
| Secondary FlyBase IDs | |||
References
( 62 ) | |||
| Generate a list of | |||
| List References by type |
| ||
Recent research papers ( 4 ) | |||
| |||

Recent Updates
External Crossreferences & Linkouts